Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

March 3, 2024

Study Completion Date

March 3, 2024

Conditions
Chlamydia Trachomatis Infection
Interventions
DIAGNOSTIC_TEST

C. trachomatis and N. gonorrhoeae

In vitro nucleic acid amplification test for the qualitative detection of Chlamydia trachomatis and/or Neisseria gonorrhea in patient specimens utilizing amplification of target DNA by the Polymerase Chain Reaction (PCR) and nucleic acid hybridization for the detection of C. trachomatis and N. gonorrhoeae.

DRUG

Azithromycin

Azithromycin 1g administered as a single oral dose

OTHER

Partner notification and treatment

Pregnant women who test positive for Chlamydia will also be suggested to take Azithromycin home to treat their spouses

Trial Locations (2)

Unknown

Dermatology Hospital of Southern Medical Hospital, Guangzhou

Nanhai Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

Southern Medical University, China

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT03862495 - Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT | Biotech Hunter | Biotech Hunter